$35m payday for Neuren as blockbuster drug takes off
SYDNEY: Neuren Pharmaceuticals, the $1.5bn ASX-listed biotech company that for a few loyal investors has
SYDNEY: Neuren Pharmaceuticals, the $1.5bn ASX-listed biotech company that for a few loyal investors has
FEATURED
Staffing in assisted living should align with resident care needs
Developers over-reach with plan for boomer “crowded house”
Boomer apartments to be woven into mixed use project
Best affordable seniors housing design for Global Awards shortlisted
Operator opens new homes for seniors in regional city
Best affordable seniors housing design for Global Awards shortlisted
INNOVATION
